Results 161 to 170 of about 222,938 (359)
Mechanism for the Stimulation in vivo of Hepatic Gluconeogenesis by Glucagon [PDF]
John Williamson
openalex +1 more source
Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS‐HF trial
Insulin resistance in heart failure with mildly reduced or preserved ejection fraction: insights from FINEARTS‐HF. CI, confidence interval; CV, cardiovascular; eGDR, estimated glucose disposal rate; HF, heart failure. Aims The estimated glucose disposal rate (eGDR) is a simple, non‐invasive measure of insulin resistance. In this exploratory analysis of
John W. Ostrominski +15 more
wiley +1 more source
EXTRACTED GLUCAGON FROM DOG PANCREAS TREATED WITH ALLOXAN, SYNTHALIN A AND COBALTOUS CHLORIDE
Yosoji Ito +4 more
openalex +2 more sources
Obesity, blood volume and ventricular remodelling. BMI, body mass index; DEXA, dual‐energy X‐ray absorptiometry; IR, increased risk; LVEDV, left ventricular end‐diastolic volume; LVEDVi, left ventricular end‐diastolic volume index. Created in BioRender. Wakeham, D.
Joseph Campain +10 more
wiley +1 more source
Response to Glucagon by Subjects with Hyperinsulinism from Islet-cell Tumours [PDF]
V. Marks
openalex +1 more source
PCP‐80% could lessen the pathophysiology of T2DM in terms of controlling blood glucose/lipid levels and enhancing intestinal barrier function, via modulating the intricate web of intestinal microbiota/BAs/BAs signaling pathways. Red vertical arrows denote increases (HPCP‐80% vs. MC), blue vertical arrows indicate decreases (HPCP‐80% vs.
Xiaole Zhao +8 more
wiley +1 more source
Metabolic syndrome is characterized by abdominal obesity, hyperglycemia, dyslipidemia, and hypertension. Bioactive compounds extracted from herbs, tea, and coffee using microbial cell factories, particularly resveratrol and caffeic acid, have demonstrated remarkable potential in the management of metabolic syndrome, offering innovative solutions for ...
Tao Li +7 more
wiley +1 more source

